复发和影响乙型肝炎表面抗原血清清除的因素,由干扰素α基疗法诱导
Rui Lu1, Meng Zhang1, Zi-Han Liu1
1Department of Infectious Diseases, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, Shaanxi Province, China.
World journal of gastroenterology
|November 29, 2024
概括
在 peg-interferon alpha (peg-IFN-α) 治疗后,乙型肝炎表面抗原 (HBsAg) 血清清除是持久的,在 84 周内复发率为 15.2%. 较短的巩固时间和乙型肝炎表面抗体的损失预测了复发.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
背景情况:
- 在peg-IFN-α治疗后HBsAg血清清除的长期稳定性尚未得到充分确立.
- 了解-IFN-α对HBsAg清除的局限性和潜力至关重要.
研究的目的:
- 通过peg-IFN-α治疗实现血清清除后评估HBsAg复发率.
- 为了确定HBsAg复发的预测因子,在接受Peg-IFN-α治疗的患者中.
主要方法:
- 一项前性多中心观察性研究 (2015年11月至2021年6月),涉及121名患者.
- 治疗后每4-12周对HBV标志物,HBVDNA和肝功能进行监测.
- 主要结局:HBV复发定义为HBsAg,HBV DNA或两者的重新出现.
主要成果:
- 随访时间中位数为84周,其中16/121名患者出现HBsAg复发.
- 累积的HBsAg复发率为15.2%.
- 巩固时间<12周和B型肝炎表面抗体的消失是复发的显著预测因素.
结论:
- 使用peg-IFN-α获得的HBsAg血清清除持续超过84周.
- 累计复发率为15.2%,凸显了需要谨慎监测的必要性.
- 识别结合时间和抗体状态等预测因素可以指导治疗后的管理.
相关概念视频
Hepatic Drug Clearance: Restrictive and Nonrestrictive Clearance
79
Hepatic clearance refers to the volume of blood cleared of a drug by the liver per unit of time. It plays a crucial role in drug metabolism and elimination. While hepatic clearance is commonly estimated by subtracting renal clearance from total body clearance, other pathways, such as pulmonary or biliary clearance, may also contribute. However, these pathways are generally less significant than hepatic and renal clearance.
Most drugs undergo restrictive clearance, which is proportional to the...
Most drugs undergo restrictive clearance, which is proportional to the...
79
Hepatic Drug Excretion: Influencing Factors
86
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
86
Hepatic Drug Clearance: Effect of Protein Binding
154
Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound.
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
154
Hepatic Drug Excretion: Enterohepatic Cycling
1.0K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
1.0K
Retrovirus Life Cycles
45.7K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.7K


